Search by Drug Name or NDC
NDC 75834-0158-05 VERAPAMIL HYDROCHLORIDE 180 mg/1 Details
VERAPAMIL HYDROCHLORIDE 180 mg/1
VERAPAMIL HYDROCHLORIDE is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Nivagen Pharmaceuticals, Inc.. The primary component is VERAPAMIL HYDROCHLORIDE.
Product Information
NDC | 75834-0158 |
---|---|
Product ID | 75834-158_ebbb0dad-ab4d-4d6c-aebb-d65e2dd08c28 |
Associated GPIs | 34000030100415 |
GCN Sequence Number | 013670 |
GCN Sequence Number Description | verapamil HCl TABLET ER 180 MG ORAL |
HIC3 | A9A |
HIC3 Description | CALCIUM CHANNEL BLOCKING AGENTS |
GCN | 32471 |
HICL Sequence Number | 000180 |
HICL Sequence Number Description | VERAPAMIL HCL |
Brand/Generic | Generic |
Proprietary Name | VERAPAMIL HYDROCHLORIDE |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | VERAPAMIL HYDROCHLORIDE |
Product Type | HUMAN PRESCRIPTION DRUG |
Dosage Form | TABLET |
Route | ORAL |
Active Ingredient Strength | 180 |
Active Ingredient Units | mg/1 |
Substance Name | VERAPAMIL HYDROCHLORIDE |
Labeler Name | Nivagen Pharmaceuticals, Inc. |
Pharmaceutical Class | Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA] |
DEA Schedule | n/a |
Marketing Category | ANDA |
Application Number | ANDA206173 |
Listing Certified Through | 2024-12-31 |
Package
NDC 75834-0158-05 (75834015805)
NDC Package Code | 75834-158-05 |
---|---|
Billing NDC | 75834015805 |
Package | 500 TABLET in 1 BOTTLE (75834-158-05) |
Marketing Start Date | 2019-05-15 |
NDC Exclude Flag | N |
Pricing Information | |
Price Per Unit | 0.19177 |
Pricing Unit | EA |
Effective Date | 2024-02-21 |
NDC Description | VERAPAMIL ER 180 MG TABLET |
Pharmacy Type Indicator | C/I |
OTC | N |
Explanation Code | 1 |
Classification for Rate Setting | G |
As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis